SEPN Septerna, Inc.

NASDAQ
$39.45

Septerna, Inc. (SEPN) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Subdued Selling ran below SEPN's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 5 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
5
18 transactions
Purchases
$0
0 shares
Sales
$5.8M
127,653 shares
Net activity
-$5.8M
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $5.8M 18 transactions · 127,653 shares
Discretionary sales $0 0 transactions · 0 shares

Largest single sale: $1.5M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Labrucherie Gil M 3 fills Chief Financial Officer Sell 10b5-1 20,000 $41.62 $832.4K 24,185 −45.3% of holding
Finer Jeffrey 5 fills Chief Executive Officer Sell 10b5-1 18,500 $43.62 $807.0K 846,809 −2.1% of holding
Ezekowitz Alan 7 fills Director Sell 10b5-1 81,820 $48.09 $3.9M 110,481 −42.5% of holding
Bhatt Elizabeth 2 fills President and COO Sell 10b5-1 4,000 $37.41 $149.6K 177,115 −2.2% of holding
Long Daniel D. SVP, Drug Discovery Sell 10b5-1 3,333 $37.83 $126.1K 96,412 −3.3% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.